期刊文献+

疏肝健脾法联合保留灌肠治疗肝郁脾虚型溃疡性直肠炎临床研究 被引量:4

Clinical Research on Ulcerative Proctitis of Liver Depression and Spleen Deficiency Pattern Treated with Liver-Dispersing and Spleen-Strengthening Method Combined with Retention Enema Therapy
暂未订购
导出
摘要 目的:观察疏肝健脾法联合保留灌肠治疗肝郁脾虚型溃疡性直肠炎的临床疗效。方法:选取2012年11月—2013年9月在本院就诊的肝郁脾虚型慢性溃疡性直肠炎患者70例,随机分为治疗组和对照组,每组35例。对照组给予甲硝唑注射液、锡类散和地塞米松混合液保留灌肠,同时口服柳氮磺吡啶片治疗;治疗组给予保留灌肠联合疏肝解郁法治疗。结果:治疗组有效率为91.43%,对照组有效率为77.14%,治疗组优于对照组(P<0.05);治疗组治疗后主要临床症状评分均优于对照组(P<0.05或P<0.01)。结论:疏肝健脾法联合保留灌肠治疗肝郁脾虚型溃疡性直肠炎疗效显著。 Objective: To observe the clinical effects of liver-dispersing and spleen-strengthening method combined with retention enema therapy on ulcerative proctitis of liver depression and spleen deficiency pattern. Methods: Totally 70 patients with ulcerative proctitis of liver depression and spleen deficiency pattern hospitalized between November 2012 and September 2013 in this hospital were randomized into treatment group and control group,with 35 cases in each group. Control group were given Metronidazole Injection,Xilei Powder and retention enema of dexamethasone mixed liquor,with simultaneous oral administration of salazosulfapyridine. Treatment group were performed with liver-dispersing and spleen-strengthening method combined with retention enema therapy. Results: The effective rate was 91. 34% in treatment group,better than 77. 14% in control group( P 〈 0. 05). After the treatment,the clinical symptom scores in treatment group were better than those in control group( P 〈 0. 05 or P 〈 0. 01). Conclusion: Liver-dispersing and spleen-strengthening method combined with retention enema therapy has remarkable therapeutic effects on ulcerative proctitis of liver depression and spleen deficiency pattern.
出处 《河南中医》 2016年第3期493-495,共3页 Henan Traditional Chinese Medicine
基金 四川省泸州医学院附属医院课题(编号:15097)
关键词 溃疡性直肠炎 疏肝健脾法 保留灌肠 ulcerative proctitis liver-dispersing and spleen-strengthening method retention enema
  • 相关文献

参考文献9

二级参考文献39

  • 1溃疡性结肠炎的诊断及疗效标准[J].中华消化杂志,1993,13(6):354-354. 被引量:1064
  • 2丁寿根.应激过程中下丘脑—垂体—肾上腺轴的调控机理[J].国外医学(军事医学分册),1994,11(1):9-14. 被引量:20
  • 3刘永军,梅浙川.瑞巴匹特的药理作用机制及临床应用[J].中国药业,2005,14(4):24-26. 被引量:8
  • 4中国炎症性肠病协作组,王玉芳,欧阳钦.3100例溃疡性结肠炎住院病例回顾分析[J].中华消化杂志,2006,26(6):368-372. 被引量:267
  • 5徐淑云 卞如濂 陈修.药理实验方法学(第2版)[M].北京:人民卫生出版社,1995.891.
  • 6Milar AD,Rampto DS,Chander CL,Nicol C.Evalvating the antioxdant potential of new treatments for inflammatory bowel disease using a rat model of coles[J].Gut,1996;39:93-9
  • 7Krawisz JE,Sharon P,Stenson WF.Quantitative assay for acute intestinalinflammation based on myelop eroxidase activity.Assessment of inflammation in rat and hamster models[J].C,astroentemlogy,1984;87:1344-50
  • 8Middleton SJ,Shorthouse M,Hunfer Jo.Increased nitric oxide synthesis ulcerative colitis[J].Lancet,1993;341:465
  • 9Tache Y,Perdue MH.Role of peripheral CRF signalling pathways in stress-related alterations of gut motility and mucosal function[J].Neurogastroenterol Motil,2004;16:137-42
  • 10Tache Y,Martinez V,Million M,Wang L.Stress and the gastrointestinal tract III.Stress-related alterations of gut motor function:role of brain corticotropin-releasing factor receptors[J].Am J Physiol Gastrointest Liver Physiol,2001;280:G173-7

共引文献1341

同被引文献42

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部